| | Nine Months Ended | |
(Unaudited, amounts in thousands) | | 1/26/19 | | 1/27/18 | |
Cash flows from operating activities | | | | | |
Net income | | $ | 68,474 | | $ | 47,235 | |
Adjustments to reconcile net income to cash provided by (used for) operating activities | | | | | |
(Gain)/Loss on disposal of assets | | 41 | | (1,849 | ) |
Gain on conversion of investment | | — | | (2,204 | ) |
Change in deferred taxes | | 2,538 | | 10,543 | |
Provision for doubtful accounts | | 477 | | 198 | |
Depreciation and amortization | | 23,182 | | 23,671 | |
Equity-based compensation expense | | 8,174 | | 7,929 | |
Pension plan contributions | | (7,000 | ) | (2,000 | ) |
Change in receivables | | 1,152 | | 5,057 | |
Change in inventories | | (18,950 | ) | (9,142 | ) |
Change in other assets | | (10,103 | ) | (3,304 | ) |
Change in payables | | 4,954 | | 12,529 | |
Change in other liabilities | | 18,509 | | 2,537 | |
Net cash provided by operating activities | | 91,448 | | 91,200 | |
| | | | | |
Cash flows from investing activities | | | | | |
Proceeds from disposals of assets | | 447 | | 620 | |
Proceeds from property insurance | | 154 | | 1,807 | |
Capital expenditures | | (35,766 | ) | (24,138 | ) |
Purchases of investments | | (14,956 | ) | (24,124 | ) |
Proceeds from sales of investments | | 14,304 | | 17,109 | |
Acquisitions, net of cash acquired | | (78,582 | ) | (16,495 | ) |
Net cash used for investing activities | | (114,399 | ) | (45,221 | ) |
| | | | | |
Cash flows from financing activities | | | | | |
Net proceeds from credit facility | | 20,000 | | — | |
Payments on debt | | (169 | ) | (203 | ) |
Payments for debt issuance costs | | — | | (220 | ) |
Stock issued for stock and employee benefit plans, net of shares withheld for taxes | | 4,012 | | 1,418 | |
Purchases of common stock | | (16,726 | ) | (46,074 | ) |
Dividends paid | | (17,381 | ) | (16,343 | ) |
Net cash used for financing activities | | (10,264 | ) | (61,422 | ) |
| | | | | |
Effect of exchange rate changes on cash and equivalents | | (74 | ) | 2,204 | |
Change in cash, cash equivalents and restricted cash | | (33,289 | ) | (13,239 | ) |
Cash, cash equivalents and restricted cash at beginning of period | | 136,871 | | 150,859 | |
Cash, cash equivalents and restricted cash at end of period | | $ | 103,582 | | $ | 137,620 | |
| | | | | |
Supplemental disclosure of non-cash investing activities | | | | | |
Capital expenditures included in payables | | $ | 2,827 | | $ | 3,926 | |